Currently Viewing:
Association of Community Cancer Centers Annual Meeting
Currently Reading
The Price of Innovation When Improving Cancer Care Delivery
March 15, 2018
Changing Trends in Oncology Practice: Value-Based Care and an Empowered Patient
March 15, 2018
Why Tom Gallo Wants to Address Burnout During His Year as ACCC President
March 15, 2018
Roger Holzberg Discusses Integrating Technology Into Healthcare
March 16, 2018
Investing in the Vital Role of a Cancer Care Coordinator
March 16, 2018
Barbara Tofani: The United States Underestimated the Need for Care Coordination
March 16, 2018
Technology Integration in Community Oncology Practice: Building the Future
March 16, 2018
Experts Emphasize the Value of Cancer Care Integration at ACCC Meeting
March 21, 2018
Tom Gallo: Burnout Needs to Be Addressed for All Members of the Care Team
April 03, 2018
Tom Gallo Discusses How Burnout Is Increasing and the Role of Technology
April 06, 2018
Dr Kathleen Blake Discusses the Impact Healthcare Industry Changes Have on Burnout
April 23, 2018
Dr Mark Soberman on the Next Generation Multidisciplinary Cancer Care Team
April 27, 2018
Dr Mark Soberman on the Importance of Communication Among Integrated Care Teams
May 01, 2018
Dr Charles Saunders Outlines the Increasing Importance of Technology in Practices
May 03, 2018
Barbara Tofani: The Old Ways of Coordinating Care Are Gone
May 07, 2018
Dr James Hamrick: Community Practices Help Increase Diversity in Clinical Trials
May 08, 2018
Dr Kathleen Blake Highlights Telltale Signs of Burnout
May 10, 2018
Dr Yousuf Zafar Discusses the Burden of Financial Toxicity and Trends Over Time
May 14, 2018
Thomas Asfeldt Highlights 3 Key Challenges to Creating Integrated Cancer Care Teams
May 15, 2018
Pamela Tobias Discusses Pulling Data from EHRs to Improve Processes
May 15, 2018
Dr Mark Soberman Discusses Integrated Care Teams in Oncology
May 16, 2018
Dr Charles Saunders Highlights Data Collection Challenges
May 18, 2018
Dr Kathleen Blake Outlines How Burnout Affects Specialties Differently
May 21, 2018
Barbara Tofani Outlines Best Practices and Mistakes of Care Coordination
May 22, 2018

Dr James Hamrick Discusses the Importance of Real-World Data

James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health, discusses the importance of real-world data and how it augments traditional clinical trial data.


James Hamrick, MD, MPH, Kaiser Permanente and Flatiron Health, discusses the importance of real-world data and how it augments traditional clinical trial data.

Transcript

What is the importance of real-world data and how do we ensure greater use of it?

Real-world data is just an enormous opportunity. So, real-world data, real-world evidence, and pragmatic clinical trials are never going to replace traditional clinical trials—they shouldn’t. They should augment them. And, so, they can make us design smarter, traditional trials.

There’s a virtuous cycle of real-world data generation, using that to generate evidence that makes us design smarter protocols for traditional trials, and then that cycles through to clinical care. So, if you think about that cycle, if you can understand, for instance, what’s happening in standard of care out in the community, and you’re writing a protocol, that’s going to inform your control arm and it’s going to make sure that the traditional trial you run gives you the relevant answers that you need and that the patients need and that the doctors need to really roll out the new treatment out into the real world.

Now, to make real-world data useful, it has to be exceptionally, scientifically rigorous. So, one thing that we’re doing at Flatiron, is we’re doing a lot of time partnering with the FDA, working on publications to be released in to the peer-reviewed literature, because we want to be very transparent on our methods and make sure that they’re completely scientifically rigorous, and that they’re vetted in the peer-review format by the scientific community. Because there’s an enormous amount of potential learning that we can have from the data that’s generated at the point of care, but you have to be very careful, so you don’t draw spurious conclusions and so that it really helps us understand what is happening in the field.

As we move toward more value-based care models, how does real-world data have more importance?

Real-world data really does have an important place in the value-based care world, because it’s going to help us understand things that we never understood before. We’ve extrapolated from traditional clinical trials what we expect to happen.

You can imagine a world where we really have a real-time snapshot of what’s going on in cancer care in the United States, and we can use that for things like understanding how reimbursement should work, how incentives should work, in order to get us all to the goals that we want, which is super high-quality care based on outcomes that patients care about, that’s at a good value. So, that’s not breaking the bank. And that if we’re going to pay a lot, we’re getting excellent results.

I think real-world data and real-world evidence, if it’s high-quality and rigorous, is really going to enable us to be smarter about how we deliver high-value care.

 
Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
x
Welcome the the new and improved AJMC.com, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up